Work

Sorafenib down-regulation of the RAS/BRAF/MEK/MAPK pathway: clinical, pathologic and PET correlation

Year: 2006

Type: article

Source: Melanoma Research

DOI: 10.1097/00008390-200609001-00177

Authors: A. Pavlick, L. Liebes, I. Osman, P. Brooks, H. Yee, D. Polsky, M. Buckley, A. Hamilton, J. Wright, F. Muggia

Institutions: New York University, National Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: University of California, San Francisco

OpenAlex ID: W2016003741

FWCI: 0.123

Cites:

Cited by: 2

Related to: 10